Katica Jankovic is a head scientific officer at EvalyteBio. She has 15+ years of industry experience across biomedical research, project management, and business development. She managed and optimized curation and data quality projects, including Target Safety Review and Carcinogenicity Risk Assessment reports ensuring compliance and accuracy. She received her PhD in Medical Sciences, from University Medical Center Groningen, Netherlands, on the topic: “Nanoparticles and stem cells for drug delivery to the brain” in 2012.
OpenTox Virtual Conference 2026
The Target Safety Review (TSR) is a foundational document that initiates target safety assessment - a systematic process for identifying, characterizing, and managing safety risks associated with drug targets. By organizing existing knowledge on a target's characteristics, biology, and disease relevance, the TSR reveals potential risks and supports mitigation strategies such as candidate refinement and project strategy adjustments. At EvalyteBio, we specialize in de-risking therapeutic targets and delivering high-impact scientific communication, drawing on industry best practices and real-world drug discovery experience. In this presentation, we will show how integrating biological, mechanistic, and safety information produces a truly robust target safety assessment. We will also examine how far AI has come in compiling TSRs, exploring its real capabilities and current limitations.